In 1712, an ironmonger named Thomas Newcomen built a machine in Dudley, England that changed the world. Not immediately. Not obviously.

Two weeks ago, I said that one of my favorite stocks right now is Pfizer (PFE). The pharmaceutical giant is in the middle of ...

Two weeks after SIC ended, I am still assimilating everything. Different pieces are connecting in my head. I would like to tell you I have a clear vision of where we are headed. Sadly, that is not ...

Earlier this month, I headed from Virginia to Florida on the Amtrak auto train. I highly recommend this option instead of ...

One of the things I’ve learned after more than two decades of SIC is that the conference doesn’t really end when the final ...

This is the Strategic Investment Conference week, and I and our attendees are drinking through a fire hose. There have been some surprises that we will go into as I start reviewing the SIC next week, ...

It’s a weird time to be a dividend investor. Dividend stocks are a great defense when there’s fear in the air. Inflation fears are real with energy-driven price increases front and center. These ...

Like many of you, I am inundated with information. Most of it is not useful or repetitive. Even filtering for relevant content and source, it feels like I’m getting many times more data than even 10 ...

I started in the financial publishing industry as a “temp” back in 2011. I spent my first week learning about the industry, and the writing style and routine of my assigned senior editor—the income ...

I’ve been traveling for a week, reading and talking to a lot of readers and friends. It seems to me there is a great deal of angst in the media and newsletters and podcasts. And the more bearish you ...